Pharmacological Management of Neurological and Psychiatric DisordersA guide that assists diagnosis and therapeutic of neurological and psychiatric disorders. It includes an introductory chapter that covers basic neuroscience and pharmacology as they pertain to the treatment of central nervous system disorders. |
Contents
F Michael Cutrer M D CHAPTER | 3 |
Schizophrenia | 27 |
Anxiety Disorders | 53 |
Copyright | |
15 other sections not shown
Common terms and phrases
abnormalities abuse acid action activity acute addition administration agents antagonists antidepressants antipsychotics anxiety anxiety disorder appear associated attacks behavioral benefit benzodiazepines blood brain carbamazepine cause cells changes chronic clinical clomipramine clozapine combination common condition considered continued controlled decrease dementia depression develop diagnosis disease dopamine dose drugs efficacy et al evidence example factors function given half-life headache important improvement increased indicated individuals inhibition inhibitors initial involved less levels limited major mechanism medications mental migraine months multiple muscle neurons occur onset opioid pain panic disorder patients pharmacological phobia possible potential present primary problems produce psychiatric receptor reduced reported require response risk schizophrenia seizures selective serotonin severe side effects significant sleep social specific SSRIs stimulants stroke studies substance suggest symptoms syndrome Table tests therapeutic therapy tics tion tolerance treat treatment trials usually weeks